Viral MCV-type II Chemokine-like Protein Antibody
R&D Systems, part of Bio-Techne | Catalog # AF697

Key Product Details
Species Reactivity
Applications
Label
Antibody Source
Product Specifications
Immunogen
Specificity
Clonality
Host
Isotype
Endotoxin Level
Scientific Data Images for Viral MCV-type II Chemokine-like Protein Antibody
MCV‑type II Chemokine‑like Protein Inhibition of CCL1/I‑309-dependent Chemotaxis and Neutralization by Viral MCV‑type II Chemokine‑like Protein Antibody.
Recombinant Viral MCV-type II Chemokine-like Protein (Catalog # 697-M3) inhibits Recombinant Human CCL1/I-309 (Catalog # 272-I) induced chemotaxis in the BaF3 mouse pro-B cell line transfected with human CCR8 in a dose-dependent manner (orange line). The amount of cells that migrated through to the lower chemotaxis chamber was measured by Resazurin (Catalog # AR002). Inhibition of Recombinant Human CCL1/I-309 (20 ng/mL) activity elicited by Recombinant Viral MCV-type II Chemokine-like Protein (0.2 µg/mL) is neutralized (green line) by increasing concentrations of Goat Anti-Viral MCV-type II Chemokine-like Protein Antigen Affinity-purified Polyclonal Antibody (Catalog # AF697). The ND50 is typically 5-20 µg/mL.Applications for Viral MCV-type II Chemokine-like Protein Antibody
Western Blot
Sample: Recombinant Viral MCV-type II Chemokine-like Protein (Catalog # 697-M3)
Neutralization
Formulation, Preparation, and Storage
Purification
Reconstitution
Formulation
Shipping
Stability & Storage
- 12 months from date of receipt, -20 to -70 °C as supplied.
- 1 month, 2 to 8 °C under sterile conditions after reconstitution.
- 6 months, -20 to -70 °C under sterile conditions after reconstitution.
Background: MCV-type II Chemokine-like Protein
Molluscum contagiosum virus (MCV) is a human cutaneous poxvirus which causes benign proliferative lesions of the skin in normal and immunocompromised individuals. Based on endonuclease cleavage patterns of viral DNA, MCV isolates can be classified into two different types, MCV type I (MCVI) and MCV type II (MCVII). Like other DNA viruses such as poxviruses and herpesviruses, MCV has been shown to encode homologs of cellular immunomodulatory proteins. These viral proteins enable the virus to evade the host immune system and enhance the ability of the virus to propogate and survive.
MC148R2 is a CC chemokine-like protein encoded by a MCV type II gene. MC148R2 cDNA encodes a putative 104 amino acid (aa) protein containing a 24 aa signal peptide that is cleaved to produce an 80 aa mature protein. The mature protein shares 89% homology to the MCV type I chemokine-like protein, MC148R1. Compared to MIP-beta, MC148R2 retains the 4 conserved cysteine residues but has a 5 aa residue deletion at the amino-terminus region which is important for receptor activation. The MCV type I and type 2 proteins do not exhibit chemotactic properties, however these proteins have been shown in vitro to inhibit the monocyte chemotaxis induced by human MIP-1 alpha as well as the binding of radiolabeled I-309 to hCCR8 transfected cells.
References
- Krathwohl, M. et al. (1997) Proc. Natl. Acad. Sci. USA 94:9875.
- Senkevich, T. et al. (1996) Science 273:813.
- Dairaghi, D.J. et al. (1999) J. Biol. Chem. 274:21569.
Long Name
Alternate Names
Additional MCV-type II Chemokine-like Protein Products
Product Documents for Viral MCV-type II Chemokine-like Protein Antibody
Product Specific Notices for Viral MCV-type II Chemokine-like Protein Antibody
For research use only